Literature DB >> 3137907

Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control program.

S Z Hirschman1, B R Meyers, K Bradbury, B Mehl, S Gendelman, B Kimelblatt.   

Abstract

A comprehensive control program for utilization of anti-microbial agents in a large tertiary university teaching hospital regulates both dosage and duration of therapy and requires the prior approval of an infectious disease specialist for utilization of restricted antimicrobial agents. Benefits of the program include more cost-effective antimicrobial therapy and increased physician education in the use of these drugs. Gross savings in pharmacy costs for antibiotics during the first year of the program (1985) amounted to +483,032 for an average monthly savings of +40,252. Gross savings for 1986 were +211,786 with monthly savings of +17,648. The control of the use of one agent may lead to overuse of another agent. Antimicrobial prescribing patterns of physicians are quickly influenced by changing regulations of the program. An ongoing surveillance and review program of in-hospital utilization of antimicrobial agents is necessary to maintain effective and flexible controls.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137907

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Antimicrobial utilization and bacterial resistance at three different hospitals.

Authors:  V Vlahović-Palcevski; M Morović; G Palcevski; L Betica-Radić
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Determinants of hospital drug expenditures in Western Europe.

Authors:  P Thürmann; S Harder
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

Review 3.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

4.  Lowering the cost of lowering the cholesterol: a formulary policy for lovastatin.

Authors:  F A Lederle; E M Rogers
Journal:  J Gen Intern Med       Date:  1990 Nov-Dec       Impact factor: 5.128

Review 5.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

6.  Audit of antibiotic usage in medium-sized general hospital over an 11-year period. The impact of antibiotic policies.

Authors:  J C McElnay; M G Scott; J Y Sidara; P Kearney
Journal:  Pharm World Sci       Date:  1995-11-24

7.  The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.

Authors:  Adalet Altunsoy; Cenk Aypak; Alpay Azap; Önder Ergönül; Ismail Balık
Journal:  Int J Med Sci       Date:  2011-05-24       Impact factor: 3.738

8.  A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in Japan.

Authors:  Yoshiaki Ikeda; Takayoshi Mamiya; Hideki Nishiyama; Shiho Narusawa; Takenao Koseki; Akihiro Mouri; Toshitaka Nabeshima
Journal:  Nagoya J Med Sci       Date:  2012-02       Impact factor: 1.131

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.